Suchergebnisse - "Claxton, David"

PubPharm (7)

1

Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells

enthalten in: Cell reports | 2023

von Qian, F. | Nettleford, S. | Zhou, J. | +15

2

Therapeutic Benefits of Selenium in Hematological Malignancies

enthalten in: International journal of molecular sciences | 2022

von Ehudin, M. | Golla, U. | Trivedi, D. | +6

3

Single agent and synergistic combinatorial efficacy of first-in-class small molecule imipridone ONC201 in hematological malignancies

enthalten in: Cell cycle (Georgetown, Tex.) | 2018

von Prabhu, V. | Talekar, M. | Lulla, A. | +16

CommentIn: Cell Cycle. 2018;17(3):277. - PMID 29285978

4

Acid ceramidase is upregulated in AML and represents a novel therapeutic target

enthalten in: Oncotarget | 2016

von Tan, S. | Liu, X. | Fox, T. | +22

5

Ceramide-tamoxifen regimen targets bioenergetic elements in acute myelogenous leukemia

enthalten in: Journal of lipid research | 2016

von Morad, S. | Ryan, T. | Neufer, P. | +12

6

Maritoclax induces apoptosis in acute myeloid leukemia cells with elevated Mcl-1 expression

enthalten in: Cancer biology & therapy | 2014

von Doi, K. | Liu, Q. | Gowda, K. | +5

7

Pyoluteorin derivatives induce Mcl-1 degradation and apoptosis in hematological cancer cells

enthalten in: Cancer biology & therapy | 2014

von Doi, K. | Gowda, K. | Liu, Q. | +7

1
[1]